Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.

Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision label was updated from v3.6.3 to v3.6.4, indicating a new version of the page's documentation or UI. This change does not alter substantive content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedRevision on the page updated from Revision: v3.6.2 to Revision: v3.6.3, indicating a small page update and refresh of the study record.SummaryDifference0.0%

- Check30 days agoChange DetectedA new revision tag v3.6.2 was added, replacing the previous v3.6.0 to indicate a newer version of the page or its underlying system. This signals a minor update to the page’s framework or content.SummaryDifference0.0%

- Check44 days agoChange DetectedGemini 1 recruitment status is updated to closed; new help/navigation links are added (How to Read a Study Record, Common Questions, How to Join a Study), and the Intervention/Treatment heading formatting is updated from 'Intervention / Treatment' to 'Intervention/Treatment' with the revision tag changed from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check51 days agoChange DetectedThe page revision has been updated from v3.5.4 to v3.5.5. This indicates a minor update to the site's underlying code or content.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4 on the page, indicating a maintenance/update to the site's backend or UI. This change does not modify study content or data.SummaryDifference0.0%

Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.